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Background: Denmark is a welfare state with a publically funded healthcare system that
includes the right to free of charge physiotherapy (FCP) for patients with chronic or
progressive disease who fulfill strict criteria. The aim of this study was to investigate the
incidence of referral to FCP in patients with a hospital diagnosis of stroke, multiple sclerosis
(MS), Parkinson’s disease (PD) and rheumatoid arthritis (RA) between 2007 and 2016.
Methods: The study was register-based and included data from The Danish National Patient
Registry and The National Health Service Registry. The study population included the four
largest disease groups receiving FCP in Denmark. The incidence of receiving FCP was
reported as the cumulated incidence proportion (CIP).
Results: The study showed that FCP was mainly initiated within the first 2 years after
diagnosis. The 2-year CIP was 8% for stroke patients, 53% for PD patients, 49% for MS
patients, and 16% for RA patients. The proportion of patients referred to FCP generally
increased over the period of the study due to more patients being referred from medical
specialists in primary care.
Conclusion: This study found substantial differences in the incidence of referral to FCP in
a Danish population of stroke, PD, MS and RA patients.
Keywords: non-pharmacologic treatment, chronic disease, progressive disease,
rehabilitation
Introduction
Patients with a chronic disease may need support to manage everyday activities and
thus maintain a meaningful life.1 Systematic reviews of chronic disease recommend
different forms of exercise, to reach a higher functional level.2–5 However, motiva-
tional and psychological factors can influence whether a person continues to be
active and how he/she self-manages this activity.6 Therefore, providing continuous
support in the chronic stage of diseases may prove beneficial.
Denmark is a welfare state with a population of 5.7 million and a publicly funded
health care system. This healthcare system includes the right to free of charge phy-
siotherapy (FCP) for patients with severe physical disability or progressive disease who
fulfill strict diagnostic criteria specified by the Ministry of Health. FCP is provided by
private primary care clinics on a contract with the Ministry of Health. Every 4 weeks,
the primary care clinics get reimbursements through the tax-financed health care
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system. In 2016 the FCP service included more than 67,000
patients and the economic burden was more than 850 million
Danish Kroner/113 million Euro (National Health Service
Registry).
The purpose of FCP is either to increase or maintain
function, or to delay loss of function by providing treatment
and team-based training. Patients are referred to FCP by
primary care or hospital-based medical specialist. The spe-
cific criteria for receiving FCP include (i) having one of 43
FCP diagnoses defined The Danish Health Authority,7 (ii)
having a severe physical disability, defined as “a person who
cannot manage her- or himself indoors for 24 hrs without
help or aids for daily personal living”, and iii) having
a prognosis that the disease will last more than 5 years. In
August 2008, FCP was expanded to include patients with
a progressive disease, defined as “an abnormal function of
the sensor-motoric system or nervous system”, and patients
in this group no longer needed a severe physical disability to
be eligible to receive FCP.
The four largest disease groups receiving FCP are
stroke, multiple sclerosis (MS), Parkinson’s disease (PD)
and rheumatoid arthritis (RA). These groups account for
more than half of the FCP population. Until now, nothing
has been published on demographics or incidence of refer-
ral in patients receiving FCP in Denmark.
Increasing elder population and the expectations of a higher
incidence of chronic disease in the future motivate more
knowledge on services such as FCP. The aim of this study is
to investigate the incidence of referral to FCP in stroke, PD,
MS and RA patients in the period from 2007 to 2016.
Materials and Methods
Data Sources
We conducted a population-based, nationwide cohort study.
All data were retrieved from Danish administrative registries
through Statistics Denmark.8 The Danish National Patient
Registry (DNPR) contains data on all hospital contacts,
including ambulatory visits, and serves as a registry for
hospital payments and thus considered largely complete.9
The National Health Service Registry (DHSR)10 contains
data on primary health care services, including amount and
type of FCP, and coverage is assumed to be good as it serves
as a registry for reimbursements.
Data were linked across registries using the personal
identification number assigned to all citizens in Denmark.11
Approval for the study was given by the Central Denmark
Region Data Protection Agency (ref nr. 1-16-02-757-17).
Study Population
We obtained data from the DNPR on all residents in Denmark
registered with a primary ICD10 diagnosis of stroke (DI60.0–
DI60.9, DI61–DI64, DG45.0–DG45.2, DG45.8, DG45.9), PD
(DG20, DG21.0–DG21.3, DG21.8–DG21.9, DG22), MS
(DG35) or RA (DM05.0, DM05.9, DM06.0, DM06.9,
DM12.3) from 1998 to 2016 (n=311,491). The validity of
stroke, PD, MS and RA diagnoses in the DNPR has pre-
viously been reported.12–15
Patients were divided into four groups, each of them
including patients diagnosed with only the specific disease
of interest (Stroke, PD, MS, RA) and a fifth mixed group
including the patients registered with two or more of the
four diseases of interest.
Based on these data, we identified patients over a 10-
year period with first-time diagnoses of stroke, PD, MS or
RA between 2007 and 2016 (by excluding patients regis-
tered with one of the four diagnoses of interest between
1998 and 2006 (n=134,668). Patients diagnosed with two
or more of the four diseases of interest (n=2109) were also
excluded. The final population therefore included 174,714
individuals with incident hospital diagnoses of stroke, PD,
MS or RA from 2007 to 2016.
Data Analysis
Data on FCP services were retrieved for all participants from
the DHSR. As the FCP services are reimbursed every 4
weeks, we defined FCP after the diagnosis as FCP reimbur-
sements >4 weeks after the date of the hospital diagnosis.
FCP before the diagnosis was defined as FCP reimburse-
ments before or up to 4 weeks after the hospital diagnosis.
The proportion of individuals with FCP was calculated as the
cumulated incidence proportion (CIP). Individuals were fol-
lowed until the first session of FCP after the hospital diag-
nosis, death (competing event), or the end of follow-up
(December 2016), whichever occurred first.
At time points 0.5, 1, 2, 3, 4, and 5 years the overall CIP
and the CIP among those not receiving FCP before the
hospital diagnosis was calculated for each of the four diag-
noses. As the level of dependence and thereby the need for
FCP may differ within the stroke sub-diagnoses, the CIP
was additionally graphed for each sub-diagnosis of stroke.
To explore time trends in the use of FCP, the CIP was
graphed separately for each calendar year of diagnosis
grouped in 2-year periods. To explore whether the legisla-
tive changes in 2008 affected the access to FCP, the CIP
was also graphed separately for the year 2007.
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All analyses were performed using STATA version 15
(StataCorp LP, College Station, Texas)
Results
Our study included 174,714 individuals. Of these, 83%
had a stroke diagnosis, 4% had a PD diagnosis, 3% had
an MS diagnosis, and 9% had an RA diagnosis. One
hundred twenty-seven thousand five hundred and thirty-
one (73%) of these individuals were followed until their
last FCP session or the end of the study period, and 47,183
(27%) died. The percentage of deceased patients within
the individual diagnoses was 30% among stroke patients,
21% among PD patients, 2% among MS patients, and 10%
among RA patients. FCP was provided for 26,152 indivi-
duals with stroke (56%), PD (16%), MS (14%) and RA
(14%). The percentage of patients receiving FCP before
the hospital diagnosis increased over the study period.
Further characteristics of the individuals receiving FCP
are presented in Table 1.
The Incidence of Referral to FCP After
the First Hospital Diagnosis
Patients with PD and MS were the quickest to begin FCP
with 20% of PD patients and 13% of MS patients starting
Table 1 Characteristics of Patients After Incident Hospital Diagnoses of Stroke, Parkinson's Disease (PD), Multiple Sclerosis (MS) and
Rheumatoid Arthritis (RA), %
Stroke (n=14,669) PD (n=4277) MS (n=3533) RA (n=3673)
Female sex 48.3 41.3 72.1 82.1
Age at FCP Initiation
0–18 years 0.5 0.1 0.9 2.0
18–39 years 2.6 0.7 37.9 12.8
40–64 years 32.1 23.3 54.4 50.9
≥65 years 64.8 76.0 6.8 34.3
Civil Status at FCP Initiation
Unmarried 12.1 7.0 33.1 18.2
Married/civil partnership 51.8 64.6 52.7 55.7
Divorced/dissolved 15.8 9.8 11.7 14.1
Widowed 20.3 18.7 2.5 12.1
Employment Status at FCP Initiation
Employed 18.5 17.3 59.1 39.1
Unemployed 0.4 0.3 2.3 1.1
Not in work force:
● < 16 years old 0.2 0.0 0.1 0.3
● Temporary leave of absence 3.7 1.0 9.9 5.6
● Retireda 71.3 76.4 17.5 43.2
● Other 5.8 4.7 10.7 10.8
Missing 0.2 0.3 0.5 0.0
Charlson Comorbidity Index at FCP Initiationb
0 point 61.8 78.3 93.5 86.6
1 point 17.8 11.3 3.5 7.1
≥ 2 points 20.4 10.5 3.1 6.3
Received FCP before hospital diagnosis, overall 14.3 45.2 27.0 33.8
Year of diagnosis 2007–2008 11.9 32.5 20.6 29.6
Year of diagnosis 2009–2010 12.5 37.1 21.9 28.6
Year of diagnosis 2011–2012 13.5 48.0 24.7 34.0
Year of diagnosis 2013–2014 14.9 51.7 33.5 37.3
Year of diagnosis 2015–2016 23.9 66.2 45.4 58.8
Notes: aIncluding early retirement. bCharlson Comorbidity Index23 calculated from DNPR data for the 5 years preceding the FCP initiation; cerebrovascular diseases were not
included in the Charlson Comorbidity Index of stroke clients; connective tissue diseases were not included in the Charlson Comorbidity Index of rheumatoid arthritis clients.
Abbreviation: FCP, Free of charge physiotherapy.
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FCP within 2 months of their diagnosis. FCP was mainly
initiated within 2 years of the first hospital diagnosis. The
overall CIP of FCP 2 years after the first hospital diagnosis
was 8% (95% Confidence Interval (CI), 8–9%)) for stroke,
53% (95% CI; 52–54%) for PD, 49% (95% CI, 48–51%)
for MS, and 16% (95% CI, 16–17%) for RA (Table 2).
The CIP among patients not receiving FCP before the
hospital diagnosis was lower (Table S1).
Patients with mild Stroke (transischemic attack and
arterial syndrome) had the lowest CIP within sub-
diagnoses of stroke (Figure S1).
The overall CIP from 2011 to 2016 was similar or
higher compared with the CIP from 2007 to 2010 (eg,
the two-year CIP for patients diagnosed with PD from
2007 to 2008 and from 2015 to 2016 was 45% and 58%,
respectively (Figure 1)). Looking only at patients not
receiving FCP before the hospital diagnosis, only PD
patients had higher CIP in the later period compared
with the earlier period (Figure 1B).
The CIP among RA patients diagnosed between 2015 and
2016 was lower compared with previous years (Figure 1A and
B). The CIP among those diagnosed with RA or PD in 2007
was lower compared with later years (Figure S2).
Discussion
Using population-based, nationwide registers, we found
that FCP was mainly initiated within the first 2 years
after the first hospital diagnosis of stroke, PD, MS or
RA. The two-year proportion of FCP was highest in PD
(53%) and MS (49%) patients and lowest in RA (16%) and
stroke (8%) patients. The proportion of patients referred to
FCP generally increased over the period of study, espe-
cially in patients with PD and MS.
To our knowledge, this is the first study to report on the
incidence of FCP in chronic disease. The study has some
limitations. Firstly, we excluded patients with two or more
diseases. As these patients presumably had lower functional
ability due to multi-morbidity, this exclusion may have
resulted in an underestimation of the number of patients
being referred for FCP. Secondly, some patients may have
received municipal physiotherapy under the law of social
services. As patients are not allowed to receive both FCP
and municipal physiotherapy, we ideally should have
included these patients as having competing events to reduce
the potential underestimation of FCP. However, data on
municipal physiotherapy have not been systematically
recorded in the 98 municipalities in Denmark.
Third, we were unable to identify and include patients
not registered in the DNPR. These patients, if any, would
likely have a higher functional ability (as they were not
hospitalized) and thus not require FCP. Excluding these
patients may have resulted in an overestimation of the
number of patients being referred for FCP. Another poten-
tial overestimation could have occurred if patients were
diagnosed in the hospital before 1998 and not hospitalized
in the subsequent period between 1998 and 2007 (the
period used to define incident patients from 2007).
However, hospitalization is likely in stroke, PD, MS and
RA patients, and therefore the risk of overestimating the
number of patients with FCP after incident hospital diag-
nosis is minimal. Finally, it should be noted that the year
of incident hospital diagnosis may not reflect the true year
of diagnosis, as some patients may have first been diag-
nosed outside the hospital, eg, by a primary care medical
specialist. This applies particularly to patients with PD and
MS, which may explain our finding that these patients
were the quickest to begin FCP. Overall it makes good
sense that FCP was mainly initiated within the first 2 years
of diagnosis. A reason for late initiation could be increased
disability over time.
Table 2 Cumulated Incidence Proportion of FCP 6 Months to 5 Years After Incident Hospital Diagnoses of Stroke, Parkinson’s
Disease (PD), Multiple Sclerosis (MS) and Rheumatoid Arthritis (RA) Between 2007 and 2016
Time Since Incident Hospital
Diagnosis
Stroke PD MS RA
n* CIP, % 95% CI) n* CIP, % (95% CI) n* CIP, % (95% CI) n* CIP, % (95% CI)
6 months 115,262 3.4 (3.3–3.5) 4136 34.5 (33.4–35.7) 4099 29.9 (28.7–31.0) 14,277 8.9 (8.5–9.4)
1 year 102,022 6.1 (6.0–6.2) 3229 43.8 (42.6–45.0) 3353 40.1 (38.8–41.3) 13,260 11.9 (11.4–12.4)
2 years 82,607 8.4 (8.2–8.5) 2147 52.9 (51.7–54.1) 2550 49.2 (47.9–50.5) 11,197 16.1 (15.5–16.7)
3 years 67,181 9.6 (9.3–9.6) 1500 57.4 (56.3–58.7) 2047 54.3 (53.0–55.6) 9353 19.3 (18.6–19.9)
4 years 54,009 10.2 (10.1–10.4) 1050 60.4 (59.2–61.6) 1599 58.2 (56.9–59.6) 7707 21.6 (20.9–22.3)
5 years 42,269 10.9 (10.7–11.0) 698 63.1 (61.9–64.3) 1259 61.1 (59.8–62.5) 6230 23.3 (22.6–24.0)
Note: n*, Number at risk.
Abbreviations: FCP, Free of charge physiotherapy; CIP, cumulated incidence proportion; CI, confidence interval.
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A possible explanation for the low proportion of stroke
patients referred to FCP is that the majority of patients had
little or no functional disability following their stroke and
thus did not require FCP. This was illustrated in patients
with mild stroke (eg, transient ischemic attack) who had
the lowest incidence of FCP indicating that FCP is related
to disease severity. Another reason could be successful
acute treatment (thrombolysis).16 A reason for the delayed
referral of stroke patients to FCP may be that patients who
have suffered a stroke commonly receive hospital and/or
A 
B 
Figure 1 Cumulative incidence proportion of FCP after incident hospital diagnoses of stroke, Parkinson's Disease (PD), Multiple Sclerosis (MS) and Rheumatoid Arthritis
(RA) by calendar year of diagnosis. (A) Overall. (B) Among those not receiving FCP before the hospital diagnosis.
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municipality-based rehabilitation for the first year
afterwards.17 The findings that stroke patients had fewer
and slower referrals to FCP compared to the other groups
and high mortality rate raise the question of whether
a more active approach in stroke patients could help to
reduce the mortality in this population.18,19 The proportion
of RA patients referred to FCP was only slightly higher
than stroke patients and substantially lower than PD and
MS patients. This is surprising, since RA, unlike a stroke
but like PD and MS, is a progressive disease. However,
patients with RA are being increasingly well treated with
medication.20 Therefore, RA patients decreased the inci-
dence of FCP in the latest study period may indicate
a reduced need for physiotherapy.
In patients with PD and MS, the proportion of patients
receiving FCP increased over the period of study. This
increase could partly be due to the growing amount of evi-
dence over recent years showing the positive effects of training
in PD and MS patients.21,22 Another reason for the increased
incidence of FCP over the study period may be the change in
legislation in August 2008, which enabled less severe disabled
patients to be referred to FCP. The very low CIP in patients
diagnosed with PD in 2007 indicates the immediate effect of
the legislative changes in this patient group (Figure S2).
The finding of similar rates of FCP over the study
period among the MS patients not receiving FCP before
the hospital diagnosis (Figure 1B) indicates that the rise of
FCP in this patient group was mostly due to more patients
being diagnosed and referred from primary care.
The current study included patients with diagnoses
registered by hospital medical specialists in the DNPR.
However, patients may be referred to FCP by a primary
care medical specialist due to other diagnoses. Therefore,
the hospital diagnoses in the DNPR do not necessarily
correspond to the FCP referral diagnoses, registered in
the DHSR. Future studies should investigate the agreement
between the diagnoses from the DNPR and the diagnoses
for which the patients receive FCP.
The finding of the very low incidence of FCP in
patients with mild stroke indicates that FCP is related to
disease severity. Future studies should retrieve data on the
degree of severity or dependence from the clinical quality
databases for stroke, MS and RA, to explore the incidence
of referral within different degrees of dependence.
Conclusion
In the current cohort, we found that FCP was mainly initiated
within the first 2 years after the first hospital diagnosis of
stroke, PD, MS or RA. The two-year proportion of FCP was
highest in patients with PD and MS and the proportion of
patients referred to FCP generally increased over the period
of study.
Abbreviations
CI, Confidence Interval; CIP, Cumulated Incidence
Proportion; FCP, Free of Charge Physiotherapy; MS,
Multiple Sclerosis; PD, Parkinson’s Disease; RA,
Rheumatoid Arthritis; RR, Risk Ratio; DNPR, the
Danish National Patient Registry; DHSR, the National
Health Service Registry.
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